Superoxide production: A procalcifying cell signalling event in osteoblastic differentiation of vascular smooth muscle cells exposed to calcification media

Free Radical Research

Volumn 42, Issue 9, 2008, Pages 789-797

  Sutra, Thibault ^a   Morena, Marion ^a,b   Bargnoux, Anne Sophie ^a,c   Caporiccio, Bertrand ^a   Canaud, Bernard ^b,c   Cristol, Jean Paul ^a,c  

^a UNIV MONTPELLIER   (France)

^b Institut de Recherche et Formation en Dialyse   (France)

^c LAPEYRONIE HOSPITAL   (France)

Author keywords

glycerophosphate; NAD(P)H oxidase; Osteoblastic differentiation; Oxidative stress; Uremia; Vascular calcification

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; DIPHENYLIODONIUM SALT; GLYCEROPHOSPHATE; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P22; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR RUNX2; UREA;

ANIMAL CELL; ARTICLE; BLOOD VESSEL CALCIFICATION; CELL DIFFERENTIATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; HUMAN; MINERALIZATION; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; GLYCEROPHOSPHATES; HYDROGEN PEROXIDE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOBLASTS; OXIDATIVE STRESS; PHOSPHORYLATION; RATS; SIGNAL TRANSDUCTION; SUPEROXIDES;

RATTUS;

EID: 57349104290     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760802400766     Document Type: Article

References (40)

1. Wayhs, R., Zelinger, A. and Raggi, P. (2002) High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol, 39, pp. 225-230.
2. Cannata-Andia, JB, Rodriguez-Garcia, M., Carrillo-Lopez, N., Naves-Diaz, M. and Diaz-Lopez, B. (2006) Vascular calcifications: Pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol, 17, pp. S267-S273.
3. Watson, KE, Bostrom, K., Ravindranath, R., Lam, T., Norton, B. and Demer, LL. (1994) TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest, 93, pp. 2106-2113.
4. Trion, A. and van der Laarse, A. (2004) Vascular smooth muscle cells and calcification in atherosclerosis. Am Heart J, 147, pp. 808-814.
5. Speer, MY, Chien, YC, Quan, M., Yang, HY, Vali, H., McKee, MD and Giachelli, CM. (2005) Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro. Cardiovasc Res, 66, pp. 324-333.
6. Katsuda, S., Okada, Y., Minamoto, T., Oda, Y., Matsui, Y. and Nakanishi, I. (1992) Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies. Arterioscler Thromb, 12, pp. 494-502.
7. Shioi, A., Katagi, M., Okuno, Y., Mori, K., Jono, S., Koyama, H. and Nishizawa, Y. (2002) Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: Roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res, 91, pp. 9-16.
8. Shioi, A., Nishizawa, Y., Jono, S., Koyama, H., Hosoi, M. and Morii, H. (1995) Beta-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 15, pp. 2003-2009.
9. Parhami, F., Morrow, AD, Balucan, J., Leitinger, N., Watson, AD, Tintut, Y., Berliner, JA and Demer, LL. (1997) Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol, 17, pp. 680-687.
10. Mudd, SH. (1985) Vascular disease and homocysteine metabolism. N Engl J Med, 313, pp. 751-753.
11. Chen, NX and Moe, SM. (2003) Arterial calcification in diabetes. Curr Diab Rep, 3, pp. 28-32.
12. Papanas, N., Symeonidis, G., Maltezos, E., Giannakis, I., Mavridis, G., Lakasas, G. and Artopoulos, I. (2005) Evaluation of aortic arch calcification in type 2 diabetic patients. Vasa, 34, pp. 113-117.
13. Knudsen, ST, Foss, CH, Poulsen, PL, Andersen, NH, Mogensen, CE and Rasmussen, LM. (2003) Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications. Eur J Endocrinol, 149, pp. 39-42.
14. Pecovnik-Balon, B. (2005) Cardiovascular calcification in patients with end-stage renal disease. Ther Apher Dial, 9, pp. 208-210.
15. Moe, SM, Duan, D., Doehle, BP, O'Neill, KD and Chen, NX. (2003) Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int, 63, pp. 1003-1011.
16. Yang, H., Curinga, G. and Giachelli, CM. (2004) Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int, 66, pp. 2293-2299.
17. Morena, M., Cristol, JP, Senecal, L., Leray-Moragues, H., Krieter, D. and Canaud, B. (2002) Oxidative stress in hemodialysis patients: Is NADPH oxidase complex the culprit?. Kidney Int Suppl, 80, pp. 109-114.
18. Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, JP and Colette, C. (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA, 295, pp. 1681-1687.
19. Griendling, KK, Sorescu, D., Lassegue, B. and Ushio-Fukai, M. (2000) Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol, 20, pp. 2175-2183.
20. Ellmark, SH, Dusting, GJ, Fui, MN, Guzzo-Pernell, N. and Drummond, GR. (2005) The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle. Cardiovasc Res, 65, pp. 495-504.
21. Itoh, S., Umemoto, S., Hiromoto, M., Toma, Y., Tomochika, Y., Aoyagi, S., Tanaka, M., Fujii, T. and Matsuzaki, M. (2002) Importance of NAD(P)H oxidase-mediated oxidative stress and contractile type smooth muscle myosin heavy chain SM2 at the early stage of atherosclerosis. Circulation, 105, pp. 2288-2295.
22. Mody, N., Parhami, F., Sarafian, TA and Demer, LL. (2001) Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med, 31, pp. 509-519.
23. Liberman, M., Bassi, E., Martinatti, MK, Lario, FC, Wosniak Jr, J., Pomerantzeff, PM and Laurindo, FR. (2008) Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol, 28, pp. 463-470.
24. Trion, A., Schutte-Bart, C., Bax, WH, Jukema, JW and van der Laarse, A. (2008) Modulation of calcification of vascular smooth muscle cells in culture by calcium antagonists, statins, and their combination. Mol Cell Biochem, 308, pp. 25-33.
25. Chen, NX, O'Neill, KD, Duan, D. and Moe, SM. (2002) Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int, 62, pp. 1724-1731.
26. Lowry, OH, Rosebrough, NJ, Farr, AL and Randall, RJ. (1951) Protein measurement with the Folin phenol reagent. J Biol Chem, 193, pp. 265-275.
27. Olesen, P., Nguyen, K., Wogensen, L., Ledet, T. and Rasmussen, LM. (2007) Calcification of human vascular smooth muscle cells: Associations with osteoprotegerin expression and acceleration by high-dose insulin. Am J Physiol Heart Circ Physiol, 292, pp. H1058-H1064.
28. Tintut, Y. and Demer, LL. (2001) Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol, 12, pp. 555-560.
29. Steitz, SA, Speer, MY, Curinga, G., Yang, HY, Haynes, P., Aebersold, R., Schinke, T., Karsenty, G. and Giachelli, CM. (2001) Smooth muscle cell phenotypic transition associated with calcification: Upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res, 89, pp. 1147-1154.
30. Tanimura, A., McGregor, DH and Anderson, HC. (1986) Calcification in atherosclerosis. I. Human studies. J Exp Pathol, 2, pp. 261-273.
31. Morena, M., Delbosc, S., Dupuy, AM, Canaud, B. and Cristol, JP. (2005) Overproduction of reactive oxygen species in end-stage renal disease patients: A potential component of hemodialysis-associated inflammation. Hemodial Int, 9, pp. 37-46.
32. Capeillere-Blandin, C., Gausson, V., Nguyen, AT, Descamps-Latscha, B., Drueke, T. and Witko-Sarsat, V. (2006) Respective role of uraemic toxins and myeloperoxidase in the uraemic state. Nephrol Dial Transplant, 21, pp. 1555-1563.
33. Castilla, P., Davalos, A., Teruel, JL, Cerrato, F., Fernandez-Lucas, M., Merino, JL, Sanchez-Martin, CC, Ortuno, J. and Lasuncion, MA. (2008) Comparative effects of dietary supplementation with red grape juice and vitamin E on production of superoxide by circulating neutrophil NADPH oxidase in hemodialysis patients. Am J Clin Nutr, 87, pp. 1053-1061.
34. Ungvari, Z., Wolin, MS and Csiszar, A. (2006) Mechanosensitive production of reactive oxygen species in endothelial and smooth muscle cells: Role in microvascular remodeling?. Antioxid Redox Signal, 8, pp. 1121-1129.
35. Jung, HH, Choi, DH and Lee, SH. (2004) Serum malondialdehyde and coronary artery disease in hemodialysis patients. Am J Nephrol, 24, pp. 537-542.
36. Taki, K., Takayama, F., Tsuruta, Y. and Niwa, T. (2006) Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients. Kidney Int 70, pp. 218-224.
37. San Martin, A, Foncea, R., Laurindo, FR, Ebensperger, R., Griendling, KK and Leighton, F. (2007) Nox1-based NADPH oxidase-derived superoxide is required for VSMC activation by advanced glycation end-products. Free Radic Biol Med, 42, pp. 1671-1679.
38. Banerjee, C., McCabe, LR, Choi, JY, Hiebert, SW, Stein, JL, Stein, GS and Lian, JB. (1997) Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem, 66, pp. 1-8.
39. Wang, FS, Wang, CJ, Sheen-Chen, SM, Kuo, YR, Chen, RF and Yang, KD. (2002) Superoxide mediates shock wave induction of ERK-dependent osteogenic transcription factor (CBFA1) and mesenchymal cell differentiation toward osteoprogenitors. J Biol Chem, 277, pp. 10931-10937.
40. Ding, HT, Wang, CG, Zhang, TL and Wang, K. (2006) Fibronectin enhances in vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells via ERK pathway. J Cell Biochem, 99, pp. 1343-1352.